For most patients, the constipation is worst during the first 3 months of treatment or during dosage increases (e.g., moving from 5mg to 7.5mg )
NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life
Alternative Peptide Options for High-Risk Individuals Individuals who determine BPC-157 sits outside their risk tolerance still have options for supporting tissue repair and recovery
Provider review and personalized plan A licensed clinician reviews your case and, if approved, creates a tailored plan based on your needs
BPC-157 capsules go through the digestive system first, so they are often discussed for gut-focused support